The thymidylate synthase enhancer region (TSER) polymorphism increases the risk of thymic lymphoid hyperplasia in patients with Myasthenia Gravis.

[1]  L. Servais,et al.  Methylome and transcriptome profiling in Myasthenia Gravis monozygotic twins. , 2017, Journal of autoimmunity.

[2]  Yuying Li,et al.  Association Between MTHFR C677T Polymorphism and Methotrexate Treatment Outcome in Rheumatoid Arthritis Patients: A Systematic Review and Meta-Analysis. , 2017, Genetic testing and molecular biomarkers.

[3]  Yuying Li,et al.  Associations between C677T and A1298C polymorphisms of MTHFR and susceptibility to rheumatoid arthritis: a systematic review and meta-analysis , 2017, Rheumatology International.

[4]  A. Marx,et al.  Thymoma related myasthenia gravis in humans and potential animal models , 2015, Experimental Neurology.

[5]  F. Coppedè.  The genetics of folate metabolism and maternal risk of birth of a child with Down syndrome and associated congenital heart defects , 2015, Front. Genet..

[6]  M. Debeljak,et al.  The association of folate pathway and DNA repair polymorphisms with susceptibility to childhood acute lymphoblastic leukemia. , 2015, Gene.

[7]  S. Berrih-Aknin,et al.  Myasthenia gravis: a comprehensive review of immune dysregulation and etiological mechanisms. , 2014, Journal of autoimmunity.

[8]  A. Tangoku,et al.  Methylation and expression profiles of MGMT gene in thymic epithelial tumors. , 2014, Lung cancer.

[9]  F. Coppedè,et al.  Gene promoter methylation in colorectal cancer and healthy adjacent mucosa specimens , 2014, Epigenetics.

[10]  M. Hayward,et al.  Thymectomy: role in the treatment of myasthenia gravis , 2013, Journal of Neurology.

[11]  M. Watanabe,et al.  Association of polymorphisms in DNMT1, DNMT3A, DNMT3B, MTHFR and MTRR genes with global DNA methylation levels and prognosis of autoimmune thyroid disease , 2012, Clinical and experimental immunology.

[12]  F. Coppedè,et al.  Folate, homocysteine, vitamin B12, and polymorphisms of genes participating in one-carbon metabolism in late-onset Alzheimer's disease patients and healthy controls. , 2012, Antioxidants & redox signaling.

[13]  J. Bai,et al.  Methionine synthase reductase A66G polymorphism contributes to tumor susceptibility: evidence from 35 case–control studies , 2012, Molecular Biology Reports.

[14]  Jun Zhang,et al.  Thymidylate synthase polymorphisms and hematological cancer risk: a meta-analysis , 2012, Leukemia & lymphoma.

[15]  Jun Wang,et al.  The association between two polymorphisms in the TYMS gene and breast cancer risk: a meta-analysis , 2011, Breast Cancer Research and Treatment.

[16]  Jing Zhu,et al.  Association study between methylenetetrahydrofolate reductase gene polymorphisms and Graves' disease , 2010, Cell biochemistry and function.

[17]  A. Tangoku,et al.  Aberrant methylation of tumour-related genes in thymic epithelial tumours. , 2009, Lung cancer.

[18]  F. Coppedè,et al.  Association of maternal polymorphisms in folate metabolizing genes with chromosome damage and risk of Down syndrome offspring , 2009, Neuroscience Letters.

[19]  F. Coppedè,et al.  Risk of Non–Hodgkin Lymphoma Associated with Polymorphisms in Folate-Metabolizing Genes , 2005, Cancer Epidemiology Biomarkers & Prevention.

[20]  Alan Hubbard,et al.  Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. , 2004, Blood.

[21]  Nils E Gilhus.  Myasthenia Gravis. , 2017, New England Journal of Medicine.

[22]  R. Rozen,et al.  Polymorphisms in the methylenetetrahydrofolate reductase gene: clinical consequences. , 2001, American journal of pharmacogenomics : genomics-related research in drug development and clinical practice.

[23]  A. Vincent,et al.  The role of T-cells in the initiation of autoantibody responses in thymoma patients. , 1999, Pathology, research and practice.

[24]  B. Eymard,et al.  [Role of the thymus in the physiopathology of myasthenia]. , 1995, Revue neurologique.